EV/EBITDA
N/A
Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| EV/EBITDA | - | – | – | – | – | – | – | – | |
| Price | $374.86 | +0.8% | -3.1% | -20.9% | -19.7% | +6.1% | +31.5% | +50.9% | |
| PE Ratio | 12.55 | +0.8% | -3.1% | -23.0% | -23.7% | -15.4% | -10.5% | -26.4% | |
| TTM Revenue | $78.01B | +2.1% | – | +2.1% | – | +7.3% | +26.0% | +39.3% | |
| TTM EPS | $29.87 | +2.7% | – | +2.7% | – | +25.5% | +46.9% | +104.9% | |
| Enterprise Value | - | – | – | – | – | – | – | – | |
| TTM EBITDA | - | – | – | – | – | – | – | – | |
| Market Cap | $83B | +0.8% | -3.1% | -21.6% | -20.7% | -0.3% | +6.9% | +3.7% |
Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1M | N/A | N/A | N/A |
| 3M | 9.94 | N/A | |
| 6M | 11.31 | N/A | |
| 1Y | 11.31 | N/A | |
| 3Y | 11.31 | N/A | |
| 5Y | 11.31 | N/A | |
| All | 11.31 | N/A |
Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1M | N/A | N/A | N/A |
| 3M | 8.53 | N/A | |
| 6M | 8.53 | N/A | |
| 1Y | 8.53 | N/A | |
| 3Y | 8.13 | N/A | |
| 5Y | 7.10 | N/A | |
| All | 5.90 | N/A |
History
FAQ
What is HCA EV/EBITDA 1-year high?
HCA EV/EBITDA reached a 1-year high of 11.31 on March 9, 2026
What is HCA EV/EBITDA 1-year low?
HCA EV/EBITDA reached a 1-year low of 8.53 on May 29, 2026
Formula
Data Sources & References
- HCA Official Website hcahealthcare.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/860730/000119312526023323/0001193125-26-023323-index.htm
- HCA Profile on Yahoo Finance finance.yahoo.com/quote/HCA
- HCA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/hca
